These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16929965)

  • 1. Lymphocyte antibody-dependent cytotoxicity test for evaluation of clinical role of monoclonal anti-D-antibodies for prevention of rhesus sensitization.
    Olovnikova NI; Belkina EV; Nikolaeva TL; Miterev GY; Chertkov IL
    Bull Exp Biol Med; 2006 Jan; 141(1):57-61. PubMed ID: 16929965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
    Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
    Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Absence of relation between activity of mono- and polyclonal anti-rhesus immunoglobulins in in vitro and in vivo tests].
    Olovnikova NI; Belkina EV; Nikolaeva TL; Chertkov IL
    Biull Eksp Biol Med; 1998 Jan; 125(1):71-4. PubMed ID: 9532373
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical value of an antibody-dependent cell-mediated cytotoxicity assay in the management of Rh D alloimmunization.
    Oepkes D; van Kamp IL; Simon MJ; Mesman J; Overbeeke MA; Kanhai HH
    Am J Obstet Gynecol; 2001 Apr; 184(5):1015-20. PubMed ID: 11303214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rh-immunoglobulin: Rh prophylaxis.
    Bowman J
    Best Pract Res Clin Haematol; 2006; 19(1):27-34. PubMed ID: 16377539
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a panel of human monoclonal antibodies to D and exploration of the synergistic effects of blending IgG1 and IgG3 antibodies on their in vitro biologic function.
    Armstrong-Fisher SS; Carter MC; Downing I; Fraser RH; Inglis GE; Allan EK; Mackie A; Prowse CV; Templeton JG; Thorpe SJ; Urbaniak SJ
    Transfusion; 1999 Sep; 39(9):1005-12. PubMed ID: 10533828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rh(O)D immune globulin products for prevention of alloimmunization during pregnancy.
    Aitken SL; Tichy EM
    Am J Health Syst Pharm; 2015 Feb; 72(4):267-76. PubMed ID: 25631833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Weak D (Du) phenotype and pregnancy].
    Stefanova A
    Akush Ginekol (Sofiia); 2005; 44(1):54-6. PubMed ID: 15853015
    [No Abstract]   [Full Text] [Related]  

  • 9. [Text of the guidelines for prevention of fetomaternal rhesus-D allo-immunization].
    College National de Gynecolegues et Obstetriciens Francais
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S131-1S135. PubMed ID: 16495839
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADCC activity of monoclonal anti-D antibodies.
    Armstrong-Fisher SS; Gray I; Todd DH; Forrest A; Urbaniak SJ
    Transfus Clin Biol; 1996; 3(6):475-7. PubMed ID: 9018811
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diagnostic and therapeutic use of human anti-D (Rho) monoclonal antibodies. Evaluation and perspectives].
    Rouger P; Goossens D; Champomier F; Tsikas G; Liberge G; Leblanc J; Richard C; Bailleul C; Salmon C
    Rev Fr Transfus Immunohematol; 1985 Dec; 28(6):671-9. PubMed ID: 3006210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
    Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
    Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of IgG1 monoclonal anti-Rh(D): an investigation using ADCC and macrophage binding assays.
    Armstrong SS; Wiener E; Garner SF; Urbaniak SJ; Contreras M
    Br J Haematol; 1987 Jun; 66(2):257-62. PubMed ID: 3038161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
    Urbaniak SJ
    Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
    [No Abstract]   [Full Text] [Related]  

  • 17. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].
    Vŭlcheva B; Spasova K
    Akush Ginekol (Sofiia); 1985; 24(2):73-6. PubMed ID: 2990248
    [No Abstract]   [Full Text] [Related]  

  • 19. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
    Tuohy JF; Sangalli M; Kim L
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADCC activity of monoclonal anti-D antibodies.
    Urbaniak SJ; Stewart GM
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):237-43. PubMed ID: 3145551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.